Cite
MLA Citation
Tatsuya Yoshida et al.. “Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer.” Lung cancer, vol. 97, 2016, pp. 43–47. http://access.bl.uk/ark:/81055/vdc_100032480035.0x000014